Retrospective Cohort Study
Copyright ©The Author(s) 2017.
World J Radiol. Sep 28, 2017; 9(9): 350-358
Published online Sep 28, 2017. doi: 10.4329/wjr.v9.i9.350
Table 1 Characteristics of patients who had both 18F-labelled fluorodeoxyglucose positron emission tomography/computed tomography and prostate magnetic resonance imaging studies
Age(yr)MRI before or after PET/CT?18F-FDG PET/CTindicationProstate SUVmaxProstate MRI indicationMRI resultPSA (ng/mL)Biopsy result
732 mo beforeBone metastases (prostate primary)3.4Negative TRUS biopsyT2aNxMx20.8Gleason 4 + 5 = 9
7211 mo afterNon-Hodgkin lymphoma2.7Elevated PSA, negative TRUS biopsyT2aNxMx8.8Gleason 5 + 3 = 8
623 mo afterCancer of unknown primary3.9Prostate cancer stagingT3bNxMx37Gleason 4 + 3 = 7
7546 mo afterHead and neck cancer3.4Active surveillanceT1NxMx2.28Gleason 4 + 3 = 7
766 mo beforeGastrointestinal stromal tumour3Elevated PSA, negative TRUS biopsyT2bNxMx150Gleason 3 + 4 = 7
7922 mo afterNon-Hodgkin lymphoma2.9Elevated PSAT2aNxMx5.4Gleason 3 + 4 = 7
6630 mo afterNon-Hodgkin lymphoma3.1Active surveillanceT2cNxMx4.8Gleason 3 + 4 = 7
7326 mo afterOesophageal cancer2.4Active surveillanceT2cNxMx7.8Gleason 3 + 3 = 6
6818 mo afterCancer of unknown primary3.9Elevated PSAT2aNxMx6.1Gleason 3 + 3 = 6
745 mo beforeOesophageal cancer3.9Elevated PSAT1NxMx7.3Gleason 3 + 3 = 6
685 mo beforeHodgkin lymphoma9.9Elevated PSA, negative biopsyNo focus of tumour4.7High-grade PIN
6539 mo beforeColorectal cancer5.2Elevated PSA, negative TRUS biopsyNo focus of tumour8.6High-grade PIN
7634 mo beforeNon-Hodgkin lymphoma4.2Elevated PSASuspicious foci bilaterally15Benign
674 mo beforeNon-Hodgkin lymphoma4.1Incidental prostatic 18F-FDG uptakeSuspicious foci bilaterally5.5Benign
7216 mo afterPyrexia of unknown origin2.7Chronic urinary infectionLikely prostatitisNot doneBiopsy not performed
781 mo afterNon-Hodgkin lymphoma3.1Elevated PSANo focus of tumour11.4Biopsy not performed
6112 mo afterLung nodule5.2Elevated PSA, positive family historyNo focus of tumour4.5Biopsy not performed
687 mo afterColorectal cancer8.8Incidental prostatic 18F-FDG uptakeNo focus of tumour3Biopsy not performed